Guest guest Posted December 11, 2003 Report Share Posted December 11, 2003 THE JOURNAL OF PEDIATRICS December 2003 . Volume 143 . Number 6 Clinical and Laboratory observations Complex regional pain syndrome after hepatitis B vaccine Wasil A. Jastaniah, MBBS, FRCPC* ,Simon Dobson, MD, FRCPC G. Lugsdin, MD, MSc, FRCPC ,Ross E. Petty, MD, PhD, FRCPC Abstract Complex regional pain syndrome, characterized by pain, autonomic dysfunction, and decreased range of motion, developed after hepatitis B vaccination in four grade-6 children since the introduction of the vaccination program in British Columbia in1992. The reaction may result from injection trauma or may be secondary to a vaccine constituent. Publishing and Reprint Information From the Divisions of Infectious and Immunological Diseases, Rheumatology, the Department of Pediatrics, University of British Columbia and British Columbia's Children's Hospital, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada *Reprints not available from the authors. Please address correspondence to Wasil Jastaniah, MBBS, FRCPC, 1043 West 7th Ave, Vancouver, British Columbia, Canada V6H 1B2.; Email: wjastan@... Submitted June 17, 2002. Revised May 16, 2003. Accepted on August 22, 2003. Copyright © 2003 by Mosby, Inc. doi:10.1067/S0022-3476(03)00536-5 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 11, 2003 Report Share Posted December 11, 2003 THE JOURNAL OF PEDIATRICS December 2003 . Volume 143 . Number 6 Clinical and Laboratory observations Complex regional pain syndrome after hepatitis B vaccine Wasil A. Jastaniah, MBBS, FRCPC* ,Simon Dobson, MD, FRCPC G. Lugsdin, MD, MSc, FRCPC ,Ross E. Petty, MD, PhD, FRCPC Abstract Complex regional pain syndrome, characterized by pain, autonomic dysfunction, and decreased range of motion, developed after hepatitis B vaccination in four grade-6 children since the introduction of the vaccination program in British Columbia in1992. The reaction may result from injection trauma or may be secondary to a vaccine constituent. Publishing and Reprint Information From the Divisions of Infectious and Immunological Diseases, Rheumatology, the Department of Pediatrics, University of British Columbia and British Columbia's Children's Hospital, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada *Reprints not available from the authors. Please address correspondence to Wasil Jastaniah, MBBS, FRCPC, 1043 West 7th Ave, Vancouver, British Columbia, Canada V6H 1B2.; Email: wjastan@... Submitted June 17, 2002. Revised May 16, 2003. Accepted on August 22, 2003. Copyright © 2003 by Mosby, Inc. doi:10.1067/S0022-3476(03)00536-5 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.